Comparison of Regional Saturation Biopsy, Targeted Biopsy, and Systematic Biopsy in Patients with Prostate-specific Antigen Levels of 4–20 ng/ml: A Prospective, Single-center, Randomized Controlled Trial by Xingkang Jiang, Mingzhe Chen et al buff.ly/3tY40ZY #UroSoMe

Radical cystectomy (RC) and trimodality therapy (TMT) yield comparable outcomes in muscle-invasive bladder cancer (MIBC)? ✨ 74.4% complete response with TMT. 🔄 23.1% recurrence rate in TMT-treated patients. ⚠️ 11.4% grade ≥3 toxicity for TMT. Does this change your practice?

Molecular Hallmarks of Prostate-specific Membrane Antigen in Treatment-naïve Prostate Cancer by Adam B. Weiner, MD et al Read the full article here: buff.ly/3ZQ8Zcc Check back later for the Editorial written by Martin Bakht #UroSoMe #MedTwitter #PCa #ProstateCancer #eururol

Contemporary ileal conduit patients show higher rates of complications than neobladder patients—postoperative (49% vs. 43.6%), wound (4.2% vs. 2.7%), genitourinary (13.1% vs. 10%), and blood transfusions (19% vs. 15.6%). Patient selection bias or improvement in neobladder

Photographer Phil Thurston captured this wave.

New year love birds 📹planetpanoramastr

Spotlight: EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent by Philip Cornford et al Full article here: europeanurology.com/article/S0302-… #eauguidelines #ProstateCancer #PCa

⚡️ Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice #BladderCancer NatureRevClinOncol nature.com/articles/s4157…

Circumcision Surgery on YouTubeTM: A Quality Assessment   You can see the free full text of the research by Şeref Coşer et al.   Link : jurolsurgery.org/articles/circu…   #circumcision #quality #reliability #global #qualityscale #modified

💸💰💵💲 The cost of treating #bladdercancer is astounding 👇Check out the latest review in European Urology "The Financial Burden of Localized and Metastatic Bladder Cancer"📉 🔗tinyurl.com/22wfuc8w Shilpa Gupta Alicia Morgans, MD, MPH Roger Li Marco Moschini Peter Black Andrea Necchi

Germline and Somatic Genomic Testing for Metastatic #ProstateCancer : ASCO Guideline ascopubs.org/doi/10.1200/JC… A systematic review was conducted by a multidisciplinary panel, analyzing literature from January 2018 to May 2024, with 14 studies meeting the inclusion criteria.

NICHOLAS MACHIAVELLI. The Rudest philosopher ever existed. His book "The Prince" has been studied by great leaders and politicians for his strategies of power and tactics to maintain control. 13 Shocking Phrases that will help you maintain control over others

Same survival, less surgery! Intermediate-risk prostate cancer patients with negative PSMA PET showed no significant difference in BCR-free survival with or without PLND. 🏥👌 🔬 A step toward precision medicine! 🔗 Details: rdcu.be/d5Yis

New paper from the Swedish National #ProstateCancer Register showing no difference in quality of life and side effects between upfront prostatectomy versus prostatectomy after a period of active surveillance via JNCI doi.org/10.1093/jncics…

The efficacy of penoscrotal decompression for refractory ischaemic #priapism: a systematic review and #metaanalysis 👉 nature.com/articles/s4144… @mohamed_urology John Hayes Vaibhav Modgil | Urological Surgeon & Andrologist Ian Pearce

Synchronous management of urethral stricture disease and #penileprosthesis implantation: a case series 👉 nature.com/articles/s4144… William Du Comb Mark Alshak The Johns Hopkins Brady Urological Institute Corey Able, MD UTMBUrology

Bladder preservation is a philosophy—not just a protocol. A 15-year journey in bladder preservation at TMC Radiation Oncology . Tata Memorial Hospital ACTREC-TMC From pioneering Adaptive Radiotherapy (ART) to safely transitioning to hypofractionation, our story, in IJROBP - The Red Journal #RadOnc #bladdercancer

New pub alert 🚨 The bladder microbiome may influence intravesical chemotherapy response in bladder cancer. 🦠💊 🧪 we tested uropathogenic E. coli (UPEC) and gemcitabine Results> • Ecoli can enter tumor cells (of course) • Inactivate gemcitabine → converting it to an

All u need to know about #optilume rdcu.be/ez7rL doi.org/10.1186/s12894… Thomas RW Herrmann Daniele Castellani Steffi Yuen Dean Elterman Carlo Giulioni Urologeman (Nariman Gadzhiev) Marcelo Wroclawski angelocafarelli AngeloCormio Jeremy Teoh #UroSoMe Springer Nature #BMCUrology European Association of Urology (EAU)

Very interesting article, to my mind oncodaily.com/insight/liang-…